The NYC-based firm aims for all-cash deals ranging from $200 million to $800 million.

Year over year growth in March slowed to 3.1%.

The company says its software can help manage operations, revenue, and expenses.

With the sector returning to health, development is following suit. Navigating the current environment, however, may require a partner.